Editorial: Autoimmune complications of modern cancer therapies.

Möhn, Nora; Renovanz, Mirjam; Hagin, David; Skripuletz, Thomas

Möhn, Nora; Renovanz, Mirjam; Hagin, David; Skripuletz, Thomas.

Afiliación

Möhn N; Department of Neurology, Hannover Medical School, Hannover, Germany.
Renovanz M; Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover (ICOG-CCCH), Hannover, Germany.
Hagin D; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Hertie Institute for Clinical Brain Research, Tuebingen, Germany.
Skripuletz T; Department of Neurosurgery, University Hospital Tuebingen, Tuebingen, Germany.

Front Immunol ; 14: 1357825, 2023.

Article en En | MEDLINE | ID: mdl-38250085

Asunto(s)

Enfermedades Autoinmunes; Neoplasias; Humanos; Neoplasias/terapia; Enfermedades Autoinmunes/etiología

Palabras clave

JAK1 and JAK2 inhibitors; biomarkers; immune checkpoint inhibitor (ICI); immunotherapy; irAE

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Neoplasias Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google